We performed KEGG enrichment analysis on 88 potential therapeutic targets of KTC for PCOS, and found that molecular mechanisms of KTC's treatment of PCOS might be related to IL-17 signaling pathway, TNF signaling pathway, p53 signaling pathway, Toll-like receptor, and so on. This evidence concerns the gene IL17A and polycystic ovary syndrome.